PolyMedica catches Medco's eye; agrees to $1.5bn merger:
This article was originally published in Clinica
Executive Summary
Shares in the mail-order diabetes supplies and services provider PolyMedica have been riding high in the last week, after the Wakefield, Massachusetts firm said it was to be bought by pharmacy benefit manager Medco Health Solutions for $53 per share. This gives the transaction a total value of $1.5bn. Franklin Lakes, New Jersey-based Medco is hoping the addition of PolyMedica's operations - which generated revenues of $675.5m and profits of $33.7m in fiscal 2007 - will enable it to better capitalise on the fast-growing $25bn diabetes care market. The transaction, slated to close in 2007, is expected to be slightly accretive to Medco's earnings in 2008.
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.